Hematology

News

VEXAS: A novel rheumatologic, hematologic syndrome that’s making waves

Author:

Jeff Evans

Bruce Jancin

Publish date: April 7, 2021

VEXAS is a novel adult-onset autoinflammatory syndrome in older men and is often associated with hematologic...

• Read More

News

FDA scrutinizes cancer therapies granted accelerated approval

Author:

Kerry Dooley Young

Publish date: March 18, 2021

The FDA is conducting a review of therapies granted accelerated approval for cancer indications.

• Read More

News

High-dose chemo no better than standard dose for B-cell lymphoma

Author:

Mark S. Lesney, PhD

Publish date: March 17, 2021

Conventional chemotherapy plus rituximab (R-CHOEP-14) was compared to high-dose chemotherapy plus rituximab...

• Read More

Conference Coverage

Bleeding disorder diagnoses delayed by years in girls and women

Author:

Neil Osterweil

Publish date: March 9, 2021

Despite girls having abnormally heavy menstrual bleeding, their families and physicians may not recognize signs...

• Read More

News

‘Phenomenal’ results with CAR T cells in R/R multiple myeloma

Author:

Roxanne Nelson, RN, BSN

Publish date: March 4, 2021

The response rate was 73% in a patient population with a median of six lines of therapy, with one-third of...

• Read More

Conference Coverage

CAR T-cell products shine in real-world setting, reveal new insights

Author:

Sharon Worcester

Publish date: February 18, 2021

Real-world CAR-T experience provides new insights for predicting outcomes in patients with DLBCL.

• Read More

News

FDA okays new CAR T-cell treatment for large B-cell lymphomas

Author:

Sharon Worcester

Publish date: February 8, 2021

The Food and Drug Administration has approved lisocabtagene maraleucel (Breyanzi), a chimeric antigen receptor (...

• Read More

News

Von Willebrand disease guidelines address women’s bleeding concerns

Author:

Neil Osterweil

Publish date: January 19, 2021

In the absence of robust evidence, the joint guidelines outline key suggestions for clinical situations covering...

• Read More

News

Concern over response to COVID-19 in patients with blood cancers

Author:

Liam Davenport

Publish date: January 12, 2021

Among patients with hematologic cancers, immune responses were less pronounced and were highly variable,...

• Read More

Conference Coverage

In COVID-19 patients, risk of bleeding rivals risk of thromboembolism

Author:

Ted Bosworth

Publish date: January 12, 2021

Trials are urgently needed to define optimal anticoagulation strategies for COVID-19 infection.

• Read More

Pages

• « first
• …
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• …
• last »